Patient Care
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
July 21, 2017
July 7, 2017
Patient Care
A boy’s growth had fallen well behind that of his twin brother, leading doctors in Abu Dhabi, UAE, to discover and surgically treat a congenital heart condition.
July 5, 2017
Talwar and colleagues randomized 100 pediatric patients receiving bidirectional superior cavopulmonary anastomosis to on-cardiopulmonary bypass (CPB) and off-CPB groups. Significantly lower anastomosis time, postoperative inotropic support, and ICU and hospital stay duration were observed in the off-CPB group.
Does Surgical Ablation Energy Source Affect Long-Term Success of the Concomitant Cox Maze Procedure?
June 29, 2017
Ad and colleagues compared outcomes in patients receiving a Cox Maze (CM) procedure with cryothermal energy only or with cryothermal and bipolar radiofrequency, with 298 patients in each group.
June 27, 2017
Mehaffey and colleagues evaluated major adverse events in 118 cardiopulmonary bypass (CPB) patients who had received methylene blue (MB) within 72 hours of CPB.
June 27, 2017
Balsam and colleagues present two cases of Mycobacterium chimaera infection following implantation of left ventricular assist devices, likely linked to bioaerosols from heater-cooler units used during surgery.
June 26, 2017
This clinical case describes the treatment of a 39-year-old patient with a rare right atrial neoplasm.
June 26, 2017
The authors analyzed long-term recurrent aortic regurgitation (AR) in 249 patients with aortic insufficiency and reimplantation procedure. Of the cusp repair techniques evaluated in the analysis, only free margin reinforcement and patch repair influenced valve durability, the former positively and the latter negatively.
June 22, 2017
The Amsterdam Investigator-initiated Absorb Strategy All-comers Trial report safety concerns identified in early results for the bioresorbable scaffold drug eluting stent. The scaffold group experienced significantly higher rates of device thrombosis than the stent group (3.5% vs 0.9%; p<0.001).